With U.S. elections nearing, European pharma giants brace for potential pricing action: analysts
With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections. The races could affect European pharma companies in a big way, and now ODDO BHF analysts are laying out potential ramifications for the industry there. Amid the intense campaigning by both parties, the “usual package of measures” on drug pricing and insurance has surfaced,… Read More »